India Enters Futuristic Healthcare Era with Genome Sequencing & Personalised Medicine

Union Minister Jitendra Singh declared India's entry into a futuristic healthcare phase focused on molecular diagnostics, genome sequencing, and personalised medicine. He highlighted initiatives like large-scale genome sequencing and the National Policy for Rare Diseases as key drivers. Singh emphasized the integration of traditional wellness systems with modern medicine and India's leadership in vaccine innovation. He stated that with a young population, early diagnosis and prevention are a national imperative.

Key Points: India's Futuristic Healthcare: Genome Sequencing & Personalised Medicine

  • Molecular diagnostics central to healthcare
  • Large-scale genome sequencing initiatives
  • National Policy for Rare Diseases 2021
  • Integration of Ayush and modern medicine
  • Indigenous vaccine leadership
2 min read

India enters futuristic healthcare phase with genome sequencing, personalised medicine: Jitendra Singh

Union Minister Jitendra Singh announces India's shift to genomics, molecular diagnostics, and personalised treatment for complex health challenges.

"India has now entered a futuristic phase where molecular diagnostics, genome sequencing, and personalised medicine are becoming central to healthcare delivery. - Jitendra Singh"

New Delhi, Jan 10

India has entered a futuristic healthcare phase with molecular diagnostics, genome sequencing, and personalised medicine, said Union Minister of State for Science & Technology, Jitendra Singh.

Speaking during his visit to the DBT-BRIC Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad, Singh said that India is now scientifically and economically equipped to take on complex health challenges through genomics, biotechnology, and preventive healthcare.

"Unlike earlier decades, when India was primarily battling infectious diseases, the country has now entered a futuristic phase where molecular diagnostics, genome sequencing, and personalised medicine are becoming central to healthcare delivery," said the Minister.

Singh also laid the foundation stone of the National Skill Development Centre, SAMARTH, and inaugurated the iDeA-NA BRIC-CDFD Technology Incubator. He noted that institutions like CDFD play a crucial role in bridging laboratory research with real-life clinical outcomes.

"India is witnessing rapid progress in genomics-led initiatives, including large-scale genome sequencing, paediatric genetic disease programmes, and pioneering work in areas such as haemophilia," he said, adding that these efforts are preparing the healthcare system for "an era of personalised treatment, where patients with similar conditions may require different therapeutic approaches".

Referring to the issue of rare diseases, the Minister said that the introduction of India's first National Policy for Rare Diseases in 2021 marked a major shift in the government's approach, reflecting foresight and openness to scientific inputs. He highlighted that detection alone is not enough, and sustained treatment must also be made affordable for affected families.

The Minister also spoke about the integrated healthcare model being promoted by the government, including the institutionalisation of traditional systems through the Ministry of Ayush and the global recognition of yoga as a preventive health tool.

"Evidence-based integration of wellness practices with modern medicine has shown positive outcomes in managing lifestyle and metabolic disorders," Singh stated.

The Minister also underscored India's leadership in vaccines and preventive healthcare, stating that indigenous innovations are now being deployed nationally and shared globally, reinforcing the country's role in global health security.

"With nearly 70 per cent of India's population below the age of 40, investing in health through early diagnosis and prevention is a national imperative," Singh said.

- IANS

Share this article:

Reader Comments

R
Rohit P
Great step forward, but the real challenge is implementation. We have brilliant labs in Hyderabad and Bengaluru, but what about primary health centres in villages? The tech must reach the last mile, not just remain in elite institutes.
A
Arjun K
Focusing on rare diseases is crucial. Many families suffer in silence due to lack of diagnosis and crippling treatment costs. The 2021 policy was a good start, but sustained, affordable treatment is the key. Hope this genomics push delivers on that promise.
S
Sarah B
The integration of Ayush with modern medicine mentioned here is interesting. An evidence-based approach combining yoga and genomics for preventive care could be a unique, holistic model for the world from India.
V
Vikram M
With our young population, early diagnosis through genome sequencing can save countless lives and reduce future healthcare burden. This is strategic thinking. The incubator for tech startups is also a smart move to foster innovation.
K
Kavya N
While the vision is commendable, I hope data privacy and ethical use of genetic information is given top priority. We need strong safeguards before rolling this out at scale.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50